Identified barriers to the adoption of POCT and frequencies of stakeholders who highlighted each by stakeholder group
| Theme | Identified barrier | Comm. | Clin. | Reg. | Industry | Patients | Total |
| Clinical | Inappropriate use of test | 1 | 1 | 1 | 0 | 1 | 4 |
| Lack of clinical utility | 1 | 4 | 0 | 2 | 0 | 7 | |
| Reduced accuracy | 0 | 2 | 2 | 0 | 0 | 4 | |
| Discourages use of clinical judgement | 0 | 1 | 0 | 1 | 0 | 2 | |
| Cultural | Lack of awareness | 0 | 0 | 0 | 2 | 0 | 2 |
| Lack of clinician buy-in | 0 | 0 | 0 | 6 | 1 | 7 | |
| Resistance to change | 4 | 0 | 1 | 2 | 0 | 7 | |
| Need for service reconfiguration | 5 | 0 | 0 | 2 | 0 | 7 | |
| Lack of Accountability | 0 | 0 | 0 | 0 | 1 | 1 | |
| Evidence | Cost of evidence generation | 0 | 1 | 0 | 2 | 0 | 3 |
| Lack of evidence | 2 | 0 | 1 | 0 | 0 | 3 | |
| Lack of evaluation methodology | 0 | 1 | 0 | 1 | 0 | 2 | |
| Repetition of small scale local studies | 0 | 0 | 0 | 3 | 0 | 3 | |
| Rate of technology development | 0 | 0 | 1 | 0 | 0 | 1 | |
| Financial | Commissioning | 1 | 0 | 0 | 0 | 3 | 4 |
| Cost of test | 5 | 3 | 1 | 3 | 2 | 14 | |
| Lack of investment in new technology | 0 | 1 | 0 | 3 | 0 | 4 | |
| Payer identification | 1 | 0 | 0 | 2 | 0 | 3 | |
| Reimbursement | 0 | 0 | 2 | 0 | 0 | 2 | |
| Siloed budgets | 1 | 1 | 1 | 1 | 0 | 4 | |
| Organisational | Asset control | 0 | 0 | 1 | 0 | 0 | 1 |
| Duration of consultation | 1 | 2 | 1 | 0 | 0 | 4 | |
| Increased workload | 2 | 1 | 0 | 1 | 0 | 3 | |
| Threat to laboratory services | 4 | 0 | 1 | 3 | 0 | 8 | |
| Reduced throughput | 0 | 0 | 1 | 0 | 0 | 1 | |
| Regulation | 0 | 0 | 0 | 2 | 0 | 2 | |
| Trust Autonomy | 0 | 0 | 0 | 2 | 0 | 2 | |
| Design and Quality Assurance | Maintenance requirements | 1 | 0 | 1 | 0 | 0 | 2 |
| Training burden | 2 | 6 | 4 | 2 | 0 | 14 | |
| Poor usability | 0 | 0 | 1 | 1 | 0 | 2 | |
| Lack of connectivity | 1 | 0 | 0 | 1 | 0 | 2 | |
| Lack of technical support | 0 | 0 | 1 | 0 | 0 | 1 |
Clin, clinicians; Comm, commissioners; Reg, regulators.